USP33 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.287600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.994990E-01
Normal-vs-Stage2
7.205500E-02
Normal-vs-Stage3
5.522300E-03
Normal-vs-Stage4
3.705200E-01
Stage1-vs-Stage2
6.742000E-01
Stage1-vs-Stage3
4.691700E-02
Stage1-vs-Stage4
5.361400E-01
Stage2-vs-Stage3
3.872400E-02
Stage2-vs-Stage4
2.923000E-01
Stage3-vs-Stage4
1.063730E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.200200E-02
Normal-vs-AfricanAmerican
2.436800E-01
Normal-vs-Asian
2.051000E-01
Caucasian-vs-AfricanAmerican
7.907400E-01
Caucasian-vs-Asian
8.444000E-01
AfricanAmerican-vs-Asian
9.315200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.895800E-02
Normal-vs-Female
1.572230E-01
Male-vs-Female
3.201400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.087640E-01
Normal-vs-Age(41-60Yrs)
1.744250E-01
Normal-vs-Age(61-80Yrs)
8.619600E-02
Normal-vs-Age(81-100Yrs)
7.141000E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.007000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.054000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.523400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.160200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.322010E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.688400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.547600E-02
Normal-vs-Daily Drinker
1.261240E-01
Normal-vs-Weekly Drinker
3.541500E-02
Normal-vs-Occasional Drinker
4.087200E-01
Normal-vs-Social Drinker
1.986780E-01
Non Drinker-vs-Daily Drinker
4.179600E-01
Non Drinker-vs-Weekly Drinker
7.815800E-01
Non Drinker-vs-Occasional Drinker
5.423800E-02
Non Drinker-vs-Social Drinker
1.006810E-01
Daily Drinker-vs-Weekly Drinker
3.874400E-01
Daily Drinker-vs-Occasional Drinker
2.938200E-01
Daily Drinker-vs-Social Drinker
4.567000E-01
Weekly Drinker-vs-Occasional Drinker
9.137700E-02
Weekly Drinker-vs-Social Drinker
1.158750E-01
Occasional Drinker-vs-Social Drinker
7.343400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.981990E-01
Normal-vs-Grade 2
4.682000E-01
Normal-vs-Grade 3
4.791800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.923200E-01
Grade 1-vs-Grade 3
9.570800E-01
Grade 1-vs-Grade 4
1.981990E-01
Grade 2-vs-Grade 3
2.892800E-01
Grade 2-vs-Grade 4
4.682000E-01
Grade 3-vs-Grade 4
4.791800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.466330E-02
Normal-vs-NonDiabetic
1.073590E-01
Diabetic-vs-NonDiabetic
7.483700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.397200E-01
Normal-vs-NoPancreatitis
7.388400E-02
Pancreatitis-vs-NoPancreatitis
7.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.031400E-01
Normal-vs-N1
6.569800E-02
N0-vs-N1
5.436000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.462650E-01
Normal-vs-TP53-NonMutant
2.320800E-01
TP53-Mutant-vs-TP53-NonMutant
6.973200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
